What's happening
This bill adds Duchenne muscular dystrophy to the required newborn screening tests in New York, pending test validation.
Why it matters
Earlier detection could improve outcomes. Adding Duchenne muscular dystrophy (DMD) to newborn screening means affected infants might be diagnosed before symptoms appear, enabling earlier interventions that could slow disease progression or improve quality of life.
Equity in access to diagnostics. Mandating this screening ensures all newborns in New York, regardless of socioeconomic background, get access to early detection for a rare but serious condition, reducing disparities in healthcare.
Healthcare system readiness. The requirement that the Wadsworth center validate the testing process ensures that only reliable, accurate tests will be used, aiming to prevent false positives or unnecessary anxiety for families while preparing the healthcare system for follow-up care.
Potential for new research and treatments. Systematic early identification could facilitate research on DMD, as more cases will be detected earlier, possibly accelerating the development and deployment of new treatments or therapies.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Add Newborn DMD Screening
Plain English, a few words. Used as the page title.
Sponsors
2 Co-sponsors
History
- Signed chap.553
- Delivered to governor
- Returned to assembly
- Passed senateVote 62–0
- 3rd reading cal.1766
- Substituted for S6814
- Referred to health
- Delivered to senate
- Passed assembly
- Ordered to third reading rules cal.157
- Rules report cal.157
- Reported
Show 2 earlier actions
- Reported referred to rules
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Test Newborns for Duchenne
Senate Floor Calendar · Sponsor Gustavo Rivera
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
5042
2023-2024 Regular Sessions
IN ASSEMBLY
February 27, 2023
Introduced by M. of A. HEVESI -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to newborn screening for duchenne muscular dystrophy
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 1 of section 2500-a of the public health law is amended by adding a new subdivision (k) to read as follows:
(k) Duchenne muscular dystrophy using a test validated by the Wadsworth center for laboratories and research.
§ 2. The Wadsworth center for laboratories and research shall undertake the process for testing validation upon the development of a test for duchenne muscular dystrophy.
§ 3. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09703-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.